Novel motif:119: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:10, 9 September 2013
name: | motif119_TCAAAANCG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006281 | DNA repair | 1.152724e-12 |
GO:0071044 | histone mRNA catabolic process | 1.162461e-11 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 3.474359e-11 |
GO:0015742 | alpha-ketoglutarate transport | 3.763384e-11 |
GO:0071173 | spindle assembly checkpoint | 5.736781e-11 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 6.334597e-11 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 1.254375e-10 |
GO:0031577 | spindle checkpoint | 1.380892e-10 |
GO:0006289 | nucleotide-excision repair | 1.786219e-10 |
GO:0000296 | spermine transport | 1.403719e-9 |
GO:0022402 | cell cycle process | 4.197584e-9 |
GO:0046940 | nucleoside monophosphate phosphorylation | 4.198050e-9 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 5.407658e-9 |
GO:0090399 | replicative senescence | 5.746870e-9 |
GO:0006259 | DNA metabolic process | 8.231544e-9 |
GO:0010754 | negative regulation of cGMP-mediated signaling | 8.419814e-9 |
GO:0043652 | engulfment of apoptotic cell | 8.419814e-9 |
GO:0002605 | negative regulation of dendritic cell antigen processing and presentation | 8.419814e-9 |
GO:0010751 | negative regulation of nitric oxide mediated signal transduction | 8.419814e-9 |
GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 8.419814e-9 |
GO:0000278 | mitotic cell cycle | 1.254074e-8 |
GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 1.464073e-8 |
GO:0010994 | free ubiquitin chain polymerization | 1.965093e-8 |
GO:0060574 | intestinal epithelial cell maturation | 1.965093e-8 |
GO:0022403 | cell cycle phase | 3.464126e-8 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 3.698434e-8 |
GO:0051329 | interphase of mitotic cell cycle | 3.763519e-8 |
GO:0045839 | negative regulation of mitosis | 4.069695e-8 |
GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport | 6.004789e-8 |
GO:0051325 | interphase | 6.506433e-8 |
GO:0032026 | response to magnesium ion | 8.199417e-8 |
GO:0040040 | thermosensory behavior | 8.324543e-8 |
GO:0032369 | negative regulation of lipid transport | 1.232340e-7 |
GO:0000075 | cell cycle checkpoint | 1.370747e-7 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 1.635937e-7 |
GO:0006975 | DNA damage induced protein phosphorylation | 1.676504e-7 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 2.705898e-7 |
GO:0032891 | negative regulation of organic acid transport | 2.861661e-7 |
GO:0051897 | positive regulation of protein kinase B signaling cascade | 3.357321e-7 |
GO:0010755 | regulation of plasminogen activation | 3.402193e-7 |
GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 3.846437e-7 |
GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 3.846437e-7 |
GO:0032074 | negative regulation of nuclease activity | 3.999737e-7 |
GO:0019087 | transformation of host cell by virus | 4.425740e-7 |
GO:0002331 | pre-B cell allelic exclusion | 4.737477e-7 |
GO:0045786 | negative regulation of cell cycle | 4.867086e-7 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 5.266035e-7 |
GO:0031123 | RNA 3'-end processing | 5.545838e-7 |
GO:0008049 | male courtship behavior | 6.153789e-7 |
GO:0006370 | mRNA capping | 6.172529e-7 |
GO:0006105 | succinate metabolic process | 6.788070e-7 |
GO:2000786 | positive regulation of autophagic vacuole assembly | 7.898829e-7 |
GO:0010591 | regulation of lamellipodium assembly | 9.657889e-7 |
GO:0043032 | positive regulation of macrophage activation | 9.766393e-7 |
GO:0043537 | negative regulation of blood vessel endothelial cell migration | 1.205986e-6 |
GO:0006333 | chromatin assembly or disassembly | 1.238268e-6 |
GO:0001953 | negative regulation of cell-matrix adhesion | 1.315346e-6 |
GO:0008334 | histone mRNA metabolic process | 1.324539e-6 |
GO:0001937 | negative regulation of endothelial cell proliferation | 1.376616e-6 |
GO:0010746 | regulation of plasma membrane long-chain fatty acid transport | 1.379589e-6 |
GO:0010458 | exit from mitosis | 1.544740e-6 |
GO:0006352 | transcription initiation, DNA-dependent | 1.664770e-6 |
GO:0042276 | error-prone translesion synthesis | 1.668503e-6 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.957254e-6 |
GO:0010812 | negative regulation of cell-substrate adhesion | 2.033759e-6 |
GO:0071156 | regulation of cell cycle arrest | 2.144280e-6 |
GO:0009452 | RNA capping | 2.415838e-6 |
GO:0016032 | viral reproduction | 2.737611e-6 |
GO:0034621 | cellular macromolecular complex subunit organization | 3.191917e-6 |
GO:0007093 | mitotic cell cycle checkpoint | 3.311577e-6 |
GO:2000119 | negative regulation of sodium-dependent phosphate transport | 3.326925e-6 |
GO:0010763 | positive regulation of fibroblast migration | 4.448622e-6 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 4.602545e-6 |
GO:0051208 | sequestering of calcium ion | 4.861809e-6 |
GO:0006413 | translational initiation | 5.810551e-6 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 6.156589e-6 |
GO:0044088 | regulation of vacuole organization | 6.305271e-6 |
GO:0090398 | cellular senescence | 6.306163e-6 |
GO:0035404 | histone-serine phosphorylation | 7.212417e-6 |
GO:0090281 | negative regulation of calcium ion import | 7.495067e-6 |
GO:0071584 | negative regulation of zinc ion import | 7.495067e-6 |
GO:0043030 | regulation of macrophage activation | 7.721590e-6 |
GO:0031081 | nuclear pore distribution | 7.846999e-6 |
GO:0060435 | bronchiole development | 8.135335e-6 |
GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 8.545554e-6 |
GO:0071460 | cellular response to cell-matrix adhesion | 8.583551e-6 |
GO:0071585 | detoxification of cadmium ion | 1.000721e-5 |
GO:0042977 | activation of JAK2 kinase activity | 1.088787e-5 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 1.201916e-5 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.253640e-5 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 1.418729e-5 |
GO:0031103 | axon regeneration | 1.470362e-5 |
GO:0051896 | regulation of protein kinase B signaling cascade | 1.493087e-5 |
GO:0048168 | regulation of neuronal synaptic plasticity | 1.606809e-5 |
GO:0002577 | regulation of antigen processing and presentation | 1.631381e-5 |
GO:0006354 | transcription elongation, DNA-dependent | 1.685750e-5 |
GO:0051895 | negative regulation of focal adhesion assembly | 1.741953e-5 |
GO:0042255 | ribosome assembly | 1.925855e-5 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.020600e-5 |
GO:0007049 | cell cycle | 2.070298e-5 |
GO:0006353 | transcription termination, DNA-dependent | 2.096556e-5 |
GO:0051340 | regulation of ligase activity | 2.108748e-5 |
GO:0031497 | chromatin assembly | 2.372152e-5 |
GO:0051168 | nuclear export | 2.390803e-5 |
GO:0010757 | negative regulation of plasminogen activation | 2.398071e-5 |
GO:0034766 | negative regulation of ion transmembrane transport | 2.491330e-5 |
GO:0051918 | negative regulation of fibrinolysis | 2.500248e-5 |
GO:0006399 | tRNA metabolic process | 2.504154e-5 |
GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 2.607509e-5 |
GO:0046165 | alcohol biosynthetic process | 2.657944e-5 |
GO:0071824 | protein-DNA complex subunit organization | 2.766995e-5 |
GO:0000726 | non-recombinational repair | 2.780699e-5 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.824992e-5 |
GO:0050908 | detection of light stimulus involved in visual perception | 2.834176e-5 |
GO:0090304 | nucleic acid metabolic process | 3.053836e-5 |
GO:0015734 | taurine transport | 3.092613e-5 |
GO:0031102 | neuron projection regeneration | 3.244889e-5 |
GO:0006302 | double-strand break repair | 3.385237e-5 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 3.564553e-5 |
GO:0006493 | protein O-linked glycosylation | 3.617999e-5 |
GO:0046449 | creatinine metabolic process | 3.816166e-5 |
GO:0006664 | glycolipid metabolic process | 4.071309e-5 |
GO:0046929 | negative regulation of neurotransmitter secretion | 4.190693e-5 |
GO:0016241 | regulation of macroautophagy | 4.190693e-5 |
GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 4.378479e-5 |
GO:0019377 | glycolipid catabolic process | 5.237222e-5 |
GO:0046467 | membrane lipid biosynthetic process | 5.305766e-5 |
GO:0007163 | establishment or maintenance of cell polarity | 5.615977e-5 |
GO:0070535 | histone H2A K63-linked ubiquitination | 6.041640e-5 |
GO:0016476 | regulation of embryonic cell shape | 6.117765e-5 |
GO:0006349 | regulation of gene expression by genetic imprinting | 6.268519e-5 |
GO:0071423 | malate transmembrane transport | 6.527006e-5 |
GO:0015709 | thiosulfate transport | 6.527006e-5 |
GO:0006756 | AMP phosphorylation | 6.527006e-5 |
GO:0010756 | positive regulation of plasminogen activation | 6.675715e-5 |
GO:0045684 | positive regulation of epidermis development | 6.714548e-5 |
GO:0034763 | negative regulation of transmembrane transport | 6.837775e-5 |
GO:0000959 | mitochondrial RNA metabolic process | 6.945213e-5 |
GO:0006974 | response to DNA damage stimulus | 7.000741e-5 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 7.400543e-5 |
GO:0007614 | short-term memory | 7.400543e-5 |
GO:0051917 | regulation of fibrinolysis | 7.471636e-5 |
GO:0042416 | dopamine biosynthetic process | 7.653220e-5 |
GO:0000723 | telomere maintenance | 8.218627e-5 |
GO:0000255 | allantoin metabolic process | 8.838430e-5 |
GO:0034728 | nucleosome organization | 8.842969e-5 |
GO:0003341 | cilium movement | 8.954789e-5 |
GO:0043525 | positive regulation of neuron apoptosis | 9.280641e-5 |
GO:0016056 | rhodopsin mediated signaling pathway | 9.398452e-5 |
GO:0043570 | maintenance of DNA repeat elements | 9.433843e-5 |
GO:0006427 | histidyl-tRNA aminoacylation | 9.733990e-5 |
GO:0046512 | sphingosine biosynthetic process | 1.036256e-4 |
GO:0072659 | protein localization in plasma membrane | 1.041781e-4 |
GO:0019530 | taurine metabolic process | 1.068911e-4 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 1.086719e-4 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.152499e-4 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 1.166211e-4 |
GO:0006405 | RNA export from nucleus | 1.167656e-4 |
GO:0045606 | positive regulation of epidermal cell differentiation | 1.196601e-4 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 1.212911e-4 |
GO:0032695 | negative regulation of interleukin-12 production | 1.225050e-4 |
GO:0006310 | DNA recombination | 1.250812e-4 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 1.264722e-4 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 1.269691e-4 |
GO:0051351 | positive regulation of ligase activity | 1.277463e-4 |
GO:0032200 | telomere organization | 1.280920e-4 |
GO:0060052 | neurofilament cytoskeleton organization | 1.289640e-4 |
GO:0042159 | lipoprotein catabolic process | 1.293594e-4 |
GO:0045727 | positive regulation of translation | 1.338897e-4 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 1.339676e-4 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 1.373587e-4 |
GO:0044260 | cellular macromolecule metabolic process | 1.378479e-4 |
GO:0010758 | regulation of macrophage chemotaxis | 1.379312e-4 |
GO:0022601 | menstrual cycle phase | 1.439221e-4 |
GO:0060179 | male mating behavior | 1.466235e-4 |
GO:0060480 | lung goblet cell differentiation | 1.466235e-4 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.528011e-4 |
GO:0007009 | plasma membrane organization | 1.541491e-4 |
GO:0031507 | heterochromatin formation | 1.589718e-4 |
GO:0051320 | S phase | 1.599711e-4 |
GO:0006406 | mRNA export from nucleus | 1.626572e-4 |
GO:0071675 | regulation of mononuclear cell migration | 1.631364e-4 |
GO:0010759 | positive regulation of macrophage chemotaxis | 1.654427e-4 |
GO:0070979 | protein K11-linked ubiquitination | 1.662709e-4 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 1.745263e-4 |
GO:0003016 | respiratory system process | 1.779070e-4 |
GO:0043277 | apoptotic cell clearance | 1.807878e-4 |
GO:0055098 | response to low-density lipoprotein particle stimulus | 1.815873e-4 |
GO:0006369 | termination of RNA polymerase II transcription | 1.818676e-4 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.889464e-4 |
GO:0031959 | mineralocorticoid receptor signaling pathway | 2.064496e-4 |
GO:0006412 | translation | 2.076111e-4 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 2.171127e-4 |
GO:0006401 | RNA catabolic process | 2.203600e-4 |
GO:0006107 | oxaloacetate metabolic process | 2.279479e-4 |
GO:0006610 | ribosomal protein import into nucleus | 2.317059e-4 |
GO:0032057 | negative regulation of translational initiation in response to stress | 2.480570e-4 |
GO:0010596 | negative regulation of endothelial cell migration | 2.500508e-4 |
GO:0030194 | positive regulation of blood coagulation | 2.563046e-4 |
GO:0002316 | follicular B cell differentiation | 2.651872e-4 |
GO:0006549 | isoleucine metabolic process | 2.651872e-4 |
GO:0035067 | negative regulation of histone acetylation | 2.660366e-4 |
GO:0070682 | proteasome regulatory particle assembly | 2.742683e-4 |
GO:0007113 | endomitotic cell cycle | 2.763257e-4 |
GO:0006600 | creatine metabolic process | 2.846669e-4 |
GO:0009225 | nucleotide-sugar metabolic process | 2.851793e-4 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 3.046351e-4 |
GO:0031124 | mRNA 3'-end processing | 3.054003e-4 |
GO:0030538 | embryonic genitalia morphogenesis | 3.102587e-4 |
GO:0016071 | mRNA metabolic process | 3.126124e-4 |
GO:0006103 | 2-oxoglutarate metabolic process | 3.179614e-4 |
GO:0006396 | RNA processing | 3.515537e-4 |
GO:0033693 | neurofilament bundle assembly | 3.525945e-4 |
GO:0034622 | cellular macromolecular complex assembly | 3.579856e-4 |
GO:0042976 | activation of Janus kinase activity | 3.612460e-4 |
GO:0007050 | cell cycle arrest | 3.636205e-4 |
GO:0071514 | genetic imprinting | 3.763112e-4 |
GO:0006390 | transcription from mitochondrial promoter | 3.810773e-4 |
GO:0032908 | regulation of transforming growth factor beta1 production | 3.865084e-4 |
GO:0045647 | negative regulation of erythrocyte differentiation | 3.868203e-4 |
GO:0000375 | RNA splicing, via transesterification reactions | 4.015677e-4 |
GO:0033119 | negative regulation of RNA splicing | 4.031128e-4 |
GO:0071622 | regulation of granulocyte chemotaxis | 4.135340e-4 |
GO:0000086 | G2/M transition of mitotic cell cycle | 4.160957e-4 |
GO:0051589 | negative regulation of neurotransmitter transport | 4.309025e-4 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 4.444155e-4 |
GO:0019303 | D-ribose catabolic process | 4.533831e-4 |
GO:0035083 | cilium axoneme assembly | 4.667493e-4 |
GO:0030148 | sphingolipid biosynthetic process | 4.834095e-4 |
GO:0019276 | UDP-N-acetylgalactosamine metabolic process | 4.922968e-4 |
GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 4.937145e-4 |
GO:0015780 | nucleotide-sugar transport | 5.011760e-4 |
GO:0070613 | regulation of protein processing | 5.028515e-4 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 5.037650e-4 |
GO:0030838 | positive regulation of actin filament polymerization | 5.107553e-4 |
GO:0042423 | catecholamine biosynthetic process | 5.204132e-4 |
GO:0000279 | M phase | 5.219944e-4 |
GO:0000084 | S phase of mitotic cell cycle | 5.426599e-4 |
GO:0032055 | negative regulation of translation in response to stress | 5.779966e-4 |
GO:0051488 | activation of anaphase-promoting complex activity | 5.804968e-4 |
GO:0000209 | protein polyubiquitination | 5.812937e-4 |
GO:0065002 | intracellular protein transmembrane transport | 5.883808e-4 |
GO:0042780 | tRNA 3'-end processing | 6.101919e-4 |
GO:0043526 | neuroprotection | 6.208094e-4 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 6.336750e-4 |
GO:0035722 | interleukin-12-mediated signaling pathway | 6.336750e-4 |
GO:0003009 | skeletal muscle contraction | 6.629595e-4 |
GO:0006101 | citrate metabolic process | 6.675428e-4 |
GO:0051028 | mRNA transport | 6.733370e-4 |
GO:0007088 | regulation of mitosis | 6.759383e-4 |
GO:0006097 | glyoxylate cycle | 6.863517e-4 |
GO:0046544 | development of secondary male sexual characteristics | 6.976966e-4 |
GO:0043631 | RNA polyadenylation | 7.059998e-4 |
GO:0014012 | peripheral nervous system axon regeneration | 7.244233e-4 |
GO:0030704 | vitelline membrane formation | 7.340737e-4 |
GO:0007126 | meiosis | 7.412811e-4 |
GO:0010957 | negative regulation of vitamin D biosynthetic process | 7.420915e-4 |
GO:0019047 | provirus integration | 7.473780e-4 |
GO:0045083 | negative regulation of interleukin-12 biosynthetic process | 7.872402e-4 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 7.872402e-4 |
GO:0022415 | viral reproductive process | 7.942287e-4 |
GO:0007442 | hindgut morphogenesis | 8.005063e-4 |
GO:0006363 | termination of RNA polymerase I transcription | 8.056760e-4 |
GO:0042104 | positive regulation of activated T cell proliferation | 8.149796e-4 |
GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning | 8.399671e-4 |
GO:0019083 | viral transcription | 8.433432e-4 |
GO:0007098 | centrosome cycle | 8.465066e-4 |
GO:0030719 | P granule organization | 8.532267e-4 |
GO:0090130 | tissue migration | 8.681762e-4 |
GO:0070231 | T cell apoptosis | 9.006848e-4 |
GO:0050680 | negative regulation of epithelial cell proliferation | 9.249603e-4 |
GO:0016339 | calcium-dependent cell-cell adhesion | 9.488768e-4 |
GO:0051293 | establishment of spindle localization | 9.596512e-4 |
GO:0046939 | nucleotide phosphorylation | 9.805689e-4 |
GO:0050820 | positive regulation of coagulation | 9.815071e-4 |
GO:2000330 | positive regulation of T-helper 17 cell lineage commitment | 9.847507e-4 |
GO:2000318 | positive regulation of T-helper 17 type immune response | 9.847507e-4 |
GO:0010955 | negative regulation of protein processing | 1.004333e-3 |
GO:0046511 | sphinganine biosynthetic process | 1.022506e-3 |
GO:0000226 | microtubule cytoskeleton organization | 1.029535e-3 |
GO:0006643 | membrane lipid metabolic process | 1.036365e-3 |
GO:0031397 | negative regulation of protein ubiquitination | 1.037094e-3 |
GO:0065004 | protein-DNA complex assembly | 1.040760e-3 |
GO:0010631 | epithelial cell migration | 1.065777e-3 |
GO:0048524 | positive regulation of viral reproduction | 1.087096e-3 |
GO:0009226 | nucleotide-sugar biosynthetic process | 1.089068e-3 |
GO:0018212 | peptidyl-tyrosine modification | 1.108913e-3 |
GO:0042407 | cristae formation | 1.126759e-3 |
GO:0035803 | egg coat formation | 1.126759e-3 |
GO:0072592 | oxygen metabolic process | 1.145771e-3 |
GO:0010966 | regulation of phosphate transport | 1.145771e-3 |
GO:0033002 | muscle cell proliferation | 1.154671e-3 |
GO:0006687 | glycosphingolipid metabolic process | 1.160809e-3 |
GO:0051301 | cell division | 1.168652e-3 |
GO:0030010 | establishment of cell polarity | 1.173373e-3 |
GO:0040001 | establishment of mitotic spindle localization | 1.199561e-3 |
GO:0000724 | double-strand break repair via homologous recombination | 1.246133e-3 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 1.260058e-3 |
GO:2000774 | positive regulation of cellular senescence | 1.266736e-3 |
GO:0035986 | senescence-associated heterochromatin focus formation | 1.266736e-3 |
GO:0060556 | regulation of vitamin D biosynthetic process | 1.279819e-3 |
GO:0033007 | negative regulation of mast cell activation involved in immune response | 1.285464e-3 |
GO:0051321 | meiotic cell cycle | 1.301646e-3 |
GO:0007341 | penetration of zona pellucida | 1.317373e-3 |
GO:0006233 | dTDP biosynthetic process | 1.318402e-3 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 1.381746e-3 |
GO:0050434 | positive regulation of viral transcription | 1.409240e-3 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 1.418760e-3 |
GO:0030889 | negative regulation of B cell proliferation | 1.445842e-3 |
GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 1.446452e-3 |
GO:0071480 | cellular response to gamma radiation | 1.464810e-3 |
GO:0008366 | axon ensheathment | 1.492495e-3 |
GO:0032890 | regulation of organic acid transport | 1.505768e-3 |
GO:0016567 | protein ubiquitination | 1.518503e-3 |
GO:0000725 | recombinational repair | 1.554751e-3 |
GO:0051726 | regulation of cell cycle | 1.583315e-3 |
GO:0060033 | anatomical structure regression | 1.596939e-3 |
GO:0006538 | glutamate catabolic process | 1.599260e-3 |
GO:0043633 | polyadenylation-dependent RNA catabolic process | 1.653904e-3 |
GO:0032287 | peripheral nervous system myelin maintenance | 1.677168e-3 |
GO:0051549 | positive regulation of keratinocyte migration | 1.682020e-3 |
GO:0006911 | phagocytosis, engulfment | 1.708613e-3 |
GO:0006414 | translational elongation | 1.728536e-3 |
GO:0046782 | regulation of viral transcription | 1.785014e-3 |
GO:0060576 | intestinal epithelial cell development | 1.822516e-3 |
GO:0008054 | cyclin catabolic process | 1.824883e-3 |
GO:0050881 | musculoskeletal movement | 1.840212e-3 |
GO:0000712 | resolution of meiotic recombination intermediates | 1.841858e-3 |
GO:0070830 | tight junction assembly | 1.867604e-3 |
GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity | 1.893049e-3 |
GO:0009138 | pyrimidine nucleoside diphosphate metabolic process | 1.917688e-3 |
GO:0002769 | natural killer cell inhibitory signaling pathway | 1.968277e-3 |
GO:0046513 | ceramide biosynthetic process | 1.995251e-3 |
GO:0000132 | establishment of mitotic spindle orientation | 2.006860e-3 |
GO:0006382 | adenosine to inosine editing | 2.031854e-3 |
GO:0006689 | ganglioside catabolic process | 2.054198e-3 |
GO:0008033 | tRNA processing | 2.062706e-3 |
GO:0042572 | retinol metabolic process | 2.085344e-3 |
GO:0050769 | positive regulation of neurogenesis | 2.092485e-3 |
GO:0019673 | GDP-mannose metabolic process | 2.102137e-3 |
GO:0015696 | ammonium transport | 2.136997e-3 |
GO:0070206 | protein trimerization | 2.249820e-3 |
GO:0002312 | B cell activation involved in immune response | 2.278861e-3 |
GO:0006573 | valine metabolic process | 2.330045e-3 |
GO:0002344 | B cell affinity maturation | 2.346531e-3 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 2.355937e-3 |
GO:0048678 | response to axon injury | 2.380657e-3 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 2.453325e-3 |
GO:0006139 | nucleobase-containing compound metabolic process | 2.484103e-3 |
GO:0045879 | negative regulation of smoothened signaling pathway | 2.554319e-3 |
GO:0019985 | translesion synthesis | 2.590416e-3 |
GO:0003219 | cardiac right ventricle formation | 2.590416e-3 |
GO:0006684 | sphingomyelin metabolic process | 2.634688e-3 |
GO:0071422 | succinate transmembrane transport | 2.715849e-3 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 2.738704e-3 |
GO:0031129 | inductive cell-cell signaling | 2.738704e-3 |
GO:0014827 | intestine smooth muscle contraction | 2.789392e-3 |
GO:2000737 | negative regulation of stem cell differentiation | 2.795916e-3 |
GO:0035020 | regulation of Rac protein signal transduction | 2.797910e-3 |
GO:0006665 | sphingolipid metabolic process | 2.918493e-3 |
GO:0032446 | protein modification by small protein conjugation | 2.966641e-3 |
GO:0042552 | myelination | 2.995048e-3 |
GO:0035411 | catenin import into nucleus | 3.001088e-3 |
GO:0032107 | regulation of response to nutrient levels | 3.018411e-3 |
GO:0007346 | regulation of mitotic cell cycle | 3.048281e-3 |
GO:2000191 | regulation of fatty acid transport | 3.103671e-3 |
GO:0006337 | nucleosome disassembly | 3.121319e-3 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 3.155280e-3 |
GO:0008089 | anterograde axon cargo transport | 3.169668e-3 |
GO:0046006 | regulation of activated T cell proliferation | 3.172595e-3 |
GO:0045919 | positive regulation of cytolysis | 3.204314e-3 |
GO:0043039 | tRNA aminoacylation | 3.212337e-3 |
GO:0071344 | diphosphate metabolic process | 3.218601e-3 |
GO:0030187 | melatonin biosynthetic process | 3.218601e-3 |
GO:0046931 | pore complex assembly | 3.443318e-3 |
GO:0030221 | basophil differentiation | 3.467032e-3 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 3.486549e-3 |
GO:0043616 | keratinocyte proliferation | 3.536227e-3 |
GO:0001936 | regulation of endothelial cell proliferation | 3.589957e-3 |
GO:0070207 | protein homotrimerization | 3.596745e-3 |
GO:0060534 | trachea cartilage development | 3.604619e-3 |
GO:0051298 | centrosome duplication | 3.678880e-3 |
GO:0048194 | Golgi vesicle budding | 3.688612e-3 |
GO:0046479 | glycosphingolipid catabolic process | 3.688612e-3 |
GO:0006913 | nucleocytoplasmic transport | 3.713870e-3 |
GO:0001893 | maternal placenta development | 3.733579e-3 |
GO:0046520 | sphingoid biosynthetic process | 3.744967e-3 |
GO:0071636 | positive regulation of transforming growth factor beta production | 3.845772e-3 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 3.896845e-3 |
GO:0055017 | cardiac muscle tissue growth | 3.922874e-3 |
GO:0009988 | cell-cell recognition | 4.112029e-3 |
GO:0006108 | malate metabolic process | 4.167103e-3 |
GO:0006334 | nucleosome assembly | 4.199097e-3 |
GO:2000177 | regulation of neural precursor cell proliferation | 4.269602e-3 |
GO:0043297 | apical junction assembly | 4.305575e-3 |
GO:0050772 | positive regulation of axonogenesis | 4.310060e-3 |
GO:0018293 | protein-FAD linkage | 4.362245e-3 |
GO:0051388 | positive regulation of nerve growth factor receptor signaling pathway | 4.362245e-3 |
GO:0010963 | regulation of L-arginine import | 4.362245e-3 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 4.362245e-3 |
GO:0021986 | habenula development | 4.396748e-3 |
GO:0001561 | fatty acid alpha-oxidation | 4.546090e-3 |
GO:0051297 | centrosome organization | 4.563155e-3 |
GO:0045556 | positive regulation of TRAIL biosynthetic process | 4.641710e-3 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 4.691423e-3 |
GO:0043415 | positive regulation of skeletal muscle tissue regeneration | 4.728447e-3 |
GO:0010693 | negative regulation of alkaline phosphatase activity | 4.728447e-3 |
GO:0071103 | DNA conformation change | 4.755634e-3 |
GO:0043648 | dicarboxylic acid metabolic process | 4.761102e-3 |
GO:0000216 | M/G1 transition of mitotic cell cycle | 4.860810e-3 |
GO:0006686 | sphingomyelin biosynthetic process | 4.918868e-3 |
GO:0045116 | protein neddylation | 4.946254e-3 |
GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process | 4.982169e-3 |
GO:0009313 | oligosaccharide catabolic process | 4.993129e-3 |
GO:0032984 | macromolecular complex disassembly | 5.002429e-3 |
GO:0002329 | pre-B cell differentiation | 5.052892e-3 |
GO:0034623 | cellular macromolecular complex disassembly | 5.084685e-3 |
GO:0019228 | regulation of action potential in neuron | 5.100547e-3 |
GO:0006612 | protein targeting to membrane | 5.132120e-3 |
GO:0015074 | DNA integration | 5.170556e-3 |
GO:0010720 | positive regulation of cell development | 5.232421e-3 |
GO:0072274 | metanephric glomerular basement membrane development | 5.233928e-3 |
GO:0072249 | metanephric glomerular visceral epithelial cell development | 5.233928e-3 |
GO:0048677 | axon extension involved in regeneration | 5.233928e-3 |
GO:0018931 | naphthalene metabolic process | 5.233928e-3 |
GO:0035284 | brain segmentation | 5.263951e-3 |
GO:0060419 | heart growth | 5.365347e-3 |
GO:0048167 | regulation of synaptic plasticity | 5.391073e-3 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 5.416900e-3 |
GO:0070995 | NADPH oxidation | 5.432148e-3 |
GO:0003218 | cardiac left ventricle formation | 5.432148e-3 |
GO:0035814 | negative regulation of renal sodium excretion | 5.453243e-3 |
GO:0045939 | negative regulation of steroid metabolic process | 5.473623e-3 |
GO:0015801 | aromatic amino acid transport | 5.487684e-3 |
GO:0055094 | response to lipoprotein stimulus | 5.504268e-3 |
GO:0060482 | lobar bronchus development | 5.548681e-3 |
GO:0043985 | histone H4-R3 methylation | 5.548681e-3 |
GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification | 5.548681e-3 |
GO:0021776 | smoothened signaling pathway involved in spinal cord motor neuron cell fate specification | 5.548681e-3 |
GO:0010894 | negative regulation of steroid biosynthetic process | 5.708628e-3 |
GO:0019060 | intracellular transport of viral proteins in host cell | 5.724285e-3 |
GO:0033004 | negative regulation of mast cell activation | 5.734555e-3 |
GO:0015804 | neutral amino acid transport | 5.767344e-3 |
GO:0051169 | nuclear transport | 5.777363e-3 |
GO:0045292 | nuclear mRNA cis splicing, via spliceosome | 5.813574e-3 |
GO:0030833 | regulation of actin filament polymerization | 5.867614e-3 |
GO:0006415 | translational termination | 5.976916e-3 |
GO:0060038 | cardiac muscle cell proliferation | 6.133955e-3 |
GO:0022417 | protein maturation by protein folding | 6.207424e-3 |
GO:0006403 | RNA localization | 6.257998e-3 |
GO:0048619 | embryonic hindgut morphogenesis | 6.290609e-3 |
GO:0008611 | ether lipid biosynthetic process | 6.462771e-3 |
GO:0006477 | protein sulfation | 6.507719e-3 |
GO:0042053 | regulation of dopamine metabolic process | 6.533977e-3 |
GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 6.579873e-3 |
GO:0018352 | protein-pyridoxal-5-phosphate linkage | 6.717439e-3 |
GO:0006418 | tRNA aminoacylation for protein translation | 6.755074e-3 |
GO:0006323 | DNA packaging | 6.981245e-3 |
GO:0043535 | regulation of blood vessel endothelial cell migration | 7.036835e-3 |
GO:0043217 | myelin maintenance | 7.042275e-3 |
GO:0019048 | virus-host interaction | 7.107281e-3 |
GO:0002544 | chronic inflammatory response | 7.165985e-3 |
GO:0010940 | positive regulation of necrotic cell death | 7.187479e-3 |
GO:0021515 | cell differentiation in spinal cord | 7.223761e-3 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 7.240678e-3 |
GO:0051292 | nuclear pore complex assembly | 7.247684e-3 |
GO:0042694 | muscle cell fate specification | 7.247684e-3 |
GO:0019323 | pentose catabolic process | 7.247684e-3 |
GO:0002339 | B cell selection | 7.247684e-3 |
GO:0016572 | histone phosphorylation | 7.272727e-3 |
GO:0006556 | S-adenosylmethionine biosynthetic process | 7.273085e-3 |
GO:0035094 | response to nicotine | 7.277367e-3 |
GO:0045333 | cellular respiration | 7.332614e-3 |
GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 7.443102e-3 |
GO:0019376 | galactolipid catabolic process | 7.443102e-3 |
GO:0031023 | microtubule organizing center organization | 7.503873e-3 |
GO:0033554 | cellular response to stress | 7.591581e-3 |
GO:0050658 | RNA transport | 7.637499e-3 |
GO:0050686 | negative regulation of mRNA processing | 7.642883e-3 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 7.647611e-3 |
GO:0006402 | mRNA catabolic process | 7.669121e-3 |
GO:0008078 | mesodermal cell migration | 7.707798e-3 |
GO:0032185 | septin cytoskeleton organization | 7.707798e-3 |
GO:0034637 | cellular carbohydrate biosynthetic process | 7.787227e-3 |
GO:0031297 | replication fork processing | 7.809477e-3 |
GO:0001881 | receptor recycling | 7.917376e-3 |
GO:0031104 | dendrite regeneration | 8.066244e-3 |
GO:0031508 | centromeric heterochromatin formation | 8.066244e-3 |
GO:0043382 | positive regulation of memory T cell differentiation | 8.159647e-3 |
GO:0010498 | proteasomal protein catabolic process | 8.246851e-3 |
GO:0042069 | regulation of catecholamine metabolic process | 8.353663e-3 |
GO:0006670 | sphingosine metabolic process | 8.376842e-3 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 8.424536e-3 |
GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development | 8.441034e-3 |
GO:0006667 | sphinganine metabolic process | 8.441034e-3 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 8.453573e-3 |
GO:0043523 | regulation of neuron apoptosis | 8.493691e-3 |
GO:0019896 | axon transport of mitochondrion | 8.536142e-3 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 8.672063e-3 |
GO:0031118 | rRNA pseudouridine synthesis | 8.701731e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0007088 | regulation of mitosis | 4.420078e-13 |
GO:0014902 | myotube differentiation | 3.526030e-12 |
GO:0045840 | positive regulation of mitosis | 1.135514e-11 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 8.416602e-11 |
GO:0007346 | regulation of mitotic cell cycle | 1.210589e-10 |
GO:0010799 | regulation of peptidyl-threonine phosphorylation | 2.141762e-10 |
GO:0051450 | myoblast proliferation | 6.888799e-10 |
GO:0010467 | gene expression | 2.058895e-9 |
GO:0010564 | regulation of cell cycle process | 8.529110e-9 |
GO:0043973 | histone H3-K4 acetylation | 1.051110e-8 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 1.051110e-8 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 1.051110e-8 |
GO:0042760 | very long-chain fatty acid catabolic process | 1.058705e-8 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.266917e-8 |
GO:0090068 | positive regulation of cell cycle process | 1.812038e-8 |
GO:0035019 | somatic stem cell maintenance | 2.439157e-8 |
GO:0035914 | skeletal muscle cell differentiation | 2.507623e-8 |
GO:0014834 | satellite cell maintenance involved in skeletal muscle regeneration | 2.624565e-8 |
GO:0060840 | artery development | 4.227257e-8 |
GO:0010801 | negative regulation of peptidyl-threonine phosphorylation | 6.217255e-8 |
GO:0031016 | pancreas development | 7.808349e-8 |
GO:0002536 | respiratory burst involved in inflammatory response | 8.403031e-8 |
GO:0034447 | very-low-density lipoprotein particle clearance | 1.082281e-7 |
GO:0014904 | myotube cell development | 2.163231e-7 |
GO:0060509 | Type I pneumocyte differentiation | 2.319856e-7 |
GO:0021533 | cell differentiation in hindbrain | 2.980526e-7 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 3.141362e-7 |
GO:0035674 | tricarboxylic acid transmembrane transport | 3.492429e-7 |
GO:0016070 | RNA metabolic process | 4.961036e-7 |
GO:0044260 | cellular macromolecule metabolic process | 5.902747e-7 |
GO:0090304 | nucleic acid metabolic process | 6.009753e-7 |
GO:0048844 | artery morphogenesis | 6.716604e-7 |
GO:0009889 | regulation of biosynthetic process | 6.756719e-7 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 7.090027e-7 |
GO:0042522 | regulation of tyrosine phosphorylation of Stat5 protein | 7.900699e-7 |
GO:0035272 | exocrine system development | 8.320308e-7 |
GO:0006401 | RNA catabolic process | 8.759538e-7 |
GO:0071354 | cellular response to interleukin-6 | 9.141512e-7 |
GO:0044237 | cellular metabolic process | 9.439644e-7 |
GO:0045862 | positive regulation of proteolysis | 1.034371e-6 |
GO:0000726 | non-recombinational repair | 1.215309e-6 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 1.256714e-6 |
GO:0007067 | mitosis | 1.836082e-6 |
GO:0048863 | stem cell differentiation | 2.087197e-6 |
GO:0000226 | microtubule cytoskeleton organization | 2.133725e-6 |
GO:0006139 | nucleobase-containing compound metabolic process | 2.248028e-6 |
GO:0045596 | negative regulation of cell differentiation | 2.278393e-6 |
GO:0032270 | positive regulation of cellular protein metabolic process | 2.312087e-6 |
GO:0031326 | regulation of cellular biosynthetic process | 2.313241e-6 |
GO:0051247 | positive regulation of protein metabolic process | 2.374680e-6 |
GO:0071243 | cellular response to arsenic-containing substance | 2.792059e-6 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 3.023700e-6 |
GO:0048285 | organelle fission | 3.297177e-6 |
GO:0060741 | prostate gland stromal morphogenesis | 3.362559e-6 |
GO:0048864 | stem cell development | 3.487678e-6 |
GO:0001764 | neuron migration | 3.663049e-6 |
GO:0000387 | spliceosomal snRNP assembly | 3.768727e-6 |
GO:0000087 | M phase of mitotic cell cycle | 3.874863e-6 |
GO:0014812 | muscle cell migration | 4.206778e-6 |
GO:0043170 | macromolecule metabolic process | 4.222550e-6 |
GO:0033238 | regulation of cellular amine metabolic process | 4.256502e-6 |
GO:0046785 | microtubule polymerization | 4.486108e-6 |
GO:0035630 | bone mineralization involved in bone maturation | 4.486108e-6 |
GO:0000089 | mitotic metaphase | 4.827022e-6 |
GO:0071034 | CUT catabolic process | 5.292461e-6 |
GO:0010994 | free ubiquitin chain polymerization | 5.292461e-6 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5.530698e-6 |
GO:0019827 | stem cell maintenance | 6.039615e-6 |
GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep | 6.167285e-6 |
GO:0042769 | DNA damage response, detection of DNA damage | 6.232567e-6 |
GO:0031017 | exocrine pancreas development | 6.495973e-6 |
GO:0008334 | histone mRNA metabolic process | 6.820555e-6 |
GO:0016055 | Wnt receptor signaling pathway | 7.753458e-6 |
GO:0008152 | metabolic process | 8.848701e-6 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 9.108496e-6 |
GO:0008380 | RNA splicing | 9.974226e-6 |
GO:0014911 | positive regulation of smooth muscle cell migration | 1.045933e-5 |
GO:0051651 | maintenance of location in cell | 1.100426e-5 |
GO:0051235 | maintenance of location | 1.101010e-5 |
GO:0060463 | lung lobe morphogenesis | 1.175399e-5 |
GO:0006396 | RNA processing | 1.206451e-5 |
GO:0043403 | skeletal muscle tissue regeneration | 1.213212e-5 |
GO:0044238 | primary metabolic process | 1.272772e-5 |
GO:0051171 | regulation of nitrogen compound metabolic process | 1.329023e-5 |
GO:0006275 | regulation of DNA replication | 1.352588e-5 |
GO:0033239 | negative regulation of cellular amine metabolic process | 1.355656e-5 |
GO:0034661 | ncRNA catabolic process | 1.372510e-5 |
GO:0015746 | citrate transport | 1.420497e-5 |
GO:0080164 | regulation of nitric oxide metabolic process | 1.458527e-5 |
GO:0007057 | spindle assembly involved in female meiosis I | 1.458527e-5 |
GO:0046777 | protein autophosphorylation | 1.638777e-5 |
GO:0042753 | positive regulation of circadian rhythm | 1.791346e-5 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.875173e-5 |
GO:0048538 | thymus development | 1.928554e-5 |
GO:0071044 | histone mRNA catabolic process | 2.021318e-5 |
GO:0034392 | negative regulation of smooth muscle cell apoptosis | 2.022027e-5 |
GO:0030970 | retrograde protein transport, ER to cytosol | 2.080766e-5 |
GO:0031536 | positive regulation of exit from mitosis | 2.156144e-5 |
GO:0044330 | canonical Wnt receptor signaling pathway involved in positive regulation of wound healing | 2.389887e-5 |
GO:0044328 | canonical Wnt receptor signaling pathway involved in positive regulation of endothelial cell migration | 2.389887e-5 |
GO:0044329 | canonical Wnt receptor signaling pathway involved in positive regulation of cell-cell adhesion | 2.389887e-5 |
GO:0001676 | long-chain fatty acid metabolic process | 2.581067e-5 |
GO:0043931 | ossification involved in bone maturation | 2.638611e-5 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 2.775428e-5 |
GO:0042104 | positive regulation of activated T cell proliferation | 2.807581e-5 |
GO:0032007 | negative regulation of TOR signaling cascade | 2.960979e-5 |
GO:0009892 | negative regulation of metabolic process | 3.072126e-5 |
GO:0016071 | mRNA metabolic process | 3.254271e-5 |
GO:0046890 | regulation of lipid biosynthetic process | 3.378148e-5 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 3.390541e-5 |
GO:0034382 | chylomicron remnant clearance | 3.390541e-5 |
GO:0009057 | macromolecule catabolic process | 3.534176e-5 |
GO:0060696 | regulation of phospholipid catabolic process | 3.559922e-5 |
GO:0060736 | prostate gland growth | 3.565835e-5 |
GO:0050995 | negative regulation of lipid catabolic process | 3.657295e-5 |
GO:0071422 | succinate transmembrane transport | 3.845123e-5 |
GO:0046426 | negative regulation of JAK-STAT cascade | 3.930469e-5 |
GO:0060319 | primitive erythrocyte differentiation | 4.096227e-5 |
GO:0060192 | negative regulation of lipase activity | 4.098473e-5 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 4.098969e-5 |
GO:0006807 | nitrogen compound metabolic process | 4.582738e-5 |
GO:0021522 | spinal cord motor neuron differentiation | 4.930215e-5 |
GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation | 4.957693e-5 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 5.197414e-5 |
GO:0033144 | negative regulation of steroid hormone receptor signaling pathway | 5.748026e-5 |
GO:0070541 | response to platinum ion | 5.873912e-5 |
GO:0070741 | response to interleukin-6 | 5.949032e-5 |
GO:0070977 | bone maturation | 6.204543e-5 |
GO:2000381 | negative regulation of mesoderm development | 6.360741e-5 |
GO:0031129 | inductive cell-cell signaling | 6.535724e-5 |
GO:0060510 | Type II pneumocyte differentiation | 6.641766e-5 |
GO:0021697 | cerebellar cortex formation | 6.644681e-5 |
GO:0051258 | protein polymerization | 7.135390e-5 |
GO:0045595 | regulation of cell differentiation | 7.287512e-5 |
GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly | 7.576855e-5 |
GO:0015931 | nucleobase-containing compound transport | 7.606559e-5 |
GO:0009059 | macromolecule biosynthetic process | 7.690191e-5 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 7.747126e-5 |
GO:0002320 | lymphoid progenitor cell differentiation | 8.091792e-5 |
GO:0048713 | regulation of oligodendrocyte differentiation | 8.579513e-5 |
GO:0007398 | ectoderm development | 8.719397e-5 |
GO:0045740 | positive regulation of DNA replication | 8.782614e-5 |
GO:0002328 | pro-B cell differentiation | 8.935279e-5 |
GO:0021515 | cell differentiation in spinal cord | 8.953442e-5 |
GO:0050810 | regulation of steroid biosynthetic process | 9.009878e-5 |
GO:0045732 | positive regulation of protein catabolic process | 9.016527e-5 |
GO:0032900 | negative regulation of neurotrophin production | 9.194669e-5 |
GO:0051315 | attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation | 9.194669e-5 |
GO:0032244 | positive regulation of nucleoside transport | 9.194669e-5 |
GO:0010468 | regulation of gene expression | 9.203553e-5 |
GO:0006397 | mRNA processing | 9.601761e-5 |
GO:0000278 | mitotic cell cycle | 9.738791e-5 |
GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein | 9.761053e-5 |
GO:2000172 | regulation of branching morphogenesis of a nerve | 9.761053e-5 |
GO:0055123 | digestive system development | 9.896534e-5 |
GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein | 9.905117e-5 |
GO:0009890 | negative regulation of biosynthetic process | 9.972568e-5 |
GO:0042752 | regulation of circadian rhythm | 1.009902e-4 |
GO:0021936 | regulation of cerebellar granule cell precursor proliferation | 1.032673e-4 |
GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep | 1.035416e-4 |
GO:0001649 | osteoblast differentiation | 1.047328e-4 |
GO:0071322 | cellular response to carbohydrate stimulus | 1.057558e-4 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.110596e-4 |
GO:0044265 | cellular macromolecule catabolic process | 1.146315e-4 |
GO:0019836 | hemolysis by symbiont of host erythrocytes | 1.160106e-4 |
GO:0060992 | response to fungicide | 1.171107e-4 |
GO:0010638 | positive regulation of organelle organization | 1.208560e-4 |
GO:0031331 | positive regulation of cellular catabolic process | 1.219502e-4 |
GO:0046006 | regulation of activated T cell proliferation | 1.225317e-4 |
GO:0010519 | negative regulation of phospholipase activity | 1.299714e-4 |
GO:0006168 | adenine salvage | 1.299714e-4 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.304767e-4 |
GO:0002244 | hemopoietic progenitor cell differentiation | 1.311948e-4 |
GO:0006699 | bile acid biosynthetic process | 1.333153e-4 |
GO:0034645 | cellular macromolecule biosynthetic process | 1.355260e-4 |
GO:0001522 | pseudouridine synthesis | 1.367608e-4 |
GO:0048333 | mesodermal cell differentiation | 1.391142e-4 |
GO:0006412 | translation | 1.565804e-4 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.602664e-4 |
GO:0060765 | regulation of androgen receptor signaling pathway | 1.607220e-4 |
GO:0060458 | right lung development | 1.624647e-4 |
GO:0021702 | cerebellar Purkinje cell differentiation | 1.637789e-4 |
GO:0034391 | regulation of smooth muscle cell apoptosis | 1.647008e-4 |
GO:0071877 | regulation of adrenergic receptor signaling pathway | 1.711481e-4 |
GO:0031327 | negative regulation of cellular biosynthetic process | 1.734861e-4 |
GO:0006284 | base-excision repair | 1.759259e-4 |
GO:0045445 | myoblast differentiation | 1.793848e-4 |
GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway | 1.828290e-4 |
GO:0060644 | mammary gland epithelial cell differentiation | 1.859579e-4 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 1.905430e-4 |
GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep | 1.909719e-4 |
GO:0010656 | negative regulation of muscle cell apoptosis | 1.948714e-4 |
GO:0014050 | negative regulation of glutamate secretion | 1.964377e-4 |
GO:0051252 | regulation of RNA metabolic process | 2.027339e-4 |
GO:0061136 | regulation of proteasomal protein catabolic process | 2.070382e-4 |
GO:0000279 | M phase | 2.096070e-4 |
GO:0048566 | embryonic digestive tract development | 2.269230e-4 |
GO:0045833 | negative regulation of lipid metabolic process | 2.339705e-4 |
GO:0006116 | NADH oxidation | 2.345986e-4 |
GO:0046325 | negative regulation of glucose import | 2.352623e-4 |
GO:0032077 | positive regulation of deoxyribonuclease activity | 2.360593e-4 |
GO:0051323 | metaphase | 2.365537e-4 |
GO:0070979 | protein K11-linked ubiquitination | 2.377335e-4 |
GO:0048012 | hepatocyte growth factor receptor signaling pathway | 2.438826e-4 |
GO:0051897 | positive regulation of protein kinase B signaling cascade | 2.463526e-4 |
GO:0021696 | cerebellar cortex morphogenesis | 2.540914e-4 |
GO:0051257 | spindle midzone assembly involved in meiosis | 2.594976e-4 |
GO:0051301 | cell division | 2.663847e-4 |
GO:0006355 | regulation of transcription, DNA-dependent | 2.685284e-4 |
GO:0021517 | ventral spinal cord development | 2.737763e-4 |
GO:0006403 | RNA localization | 2.761243e-4 |
GO:0071773 | cellular response to BMP stimulus | 2.833729e-4 |
GO:0045540 | regulation of cholesterol biosynthetic process | 2.836392e-4 |
GO:0060070 | canonical Wnt receptor signaling pathway | 2.877605e-4 |
GO:0031324 | negative regulation of cellular metabolic process | 2.936140e-4 |
GO:0060574 | intestinal epithelial cell maturation | 3.035557e-4 |
GO:0051093 | negative regulation of developmental process | 3.181266e-4 |
GO:0031133 | regulation of axon diameter | 3.234599e-4 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 3.320270e-4 |
GO:0016075 | rRNA catabolic process | 3.336672e-4 |
GO:0010458 | exit from mitosis | 3.377606e-4 |
GO:0010829 | negative regulation of glucose transport | 3.386597e-4 |
GO:0051052 | regulation of DNA metabolic process | 3.647817e-4 |
GO:0007040 | lysosome organization | 3.712973e-4 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 3.726327e-4 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 3.800684e-4 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 3.853408e-4 |
GO:0019216 | regulation of lipid metabolic process | 3.887490e-4 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 3.970970e-4 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 4.152649e-4 |
GO:0032878 | regulation of establishment or maintenance of cell polarity | 4.197830e-4 |
GO:0031109 | microtubule polymerization or depolymerization | 4.197830e-4 |
GO:0032864 | activation of Cdc42 GTPase activity | 4.208547e-4 |
GO:0044249 | cellular biosynthetic process | 4.293983e-4 |
GO:0034241 | positive regulation of macrophage fusion | 4.386233e-4 |
GO:0031468 | nuclear envelope reassembly | 4.386233e-4 |
GO:0050793 | regulation of developmental process | 4.494609e-4 |
GO:0045187 | regulation of circadian sleep/wake cycle, sleep | 4.499364e-4 |
GO:0060348 | bone development | 4.592293e-4 |
GO:0006561 | proline biosynthetic process | 4.661484e-4 |
GO:0035414 | negative regulation of catenin import into nucleus | 4.738128e-4 |
GO:0009058 | biosynthetic process | 4.790021e-4 |
GO:0019835 | cytolysis | 4.885615e-4 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 4.890429e-4 |
GO:0060981 | cell migration involved in coronary angiogenesis | 4.938493e-4 |
GO:0046038 | GMP catabolic process | 4.938493e-4 |
GO:0071670 | smooth muscle cell chemotaxis | 4.938493e-4 |
GO:0006178 | guanine salvage | 4.938493e-4 |
GO:0032263 | GMP salvage | 4.938493e-4 |
GO:0032264 | IMP salvage | 4.938493e-4 |
GO:0010629 | negative regulation of gene expression | 4.989802e-4 |
GO:0010001 | glial cell differentiation | 5.087415e-4 |
GO:0060688 | regulation of morphogenesis of a branching structure | 5.183358e-4 |
GO:0006402 | mRNA catabolic process | 5.196938e-4 |
GO:0080090 | regulation of primary metabolic process | 5.212809e-4 |
GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration | 5.403265e-4 |
GO:0001708 | cell fate specification | 5.435534e-4 |
GO:0051640 | organelle localization | 5.482137e-4 |
GO:0007017 | microtubule-based process | 5.546717e-4 |
GO:0046037 | GMP metabolic process | 5.561372e-4 |
GO:0051152 | positive regulation of smooth muscle cell differentiation | 5.662906e-4 |
GO:0051310 | metaphase plate congression | 5.714209e-4 |
GO:0051642 | centrosome localization | 5.848652e-4 |
GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway | 5.856872e-4 |
GO:0060662 | salivary gland cavitation | 6.031043e-4 |
GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 6.141902e-4 |
GO:0010605 | negative regulation of macromolecule metabolic process | 6.163226e-4 |
GO:0000212 | meiotic spindle organization | 6.199222e-4 |
GO:0010660 | regulation of muscle cell apoptosis | 6.204943e-4 |
GO:0042176 | regulation of protein catabolic process | 6.207906e-4 |
GO:2000179 | positive regulation of neural precursor cell proliferation | 6.237261e-4 |
GO:0015986 | ATP synthesis coupled proton transport | 6.343851e-4 |
GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein | 6.483003e-4 |
GO:0071294 | cellular response to zinc ion | 6.510037e-4 |
GO:0051574 | positive regulation of histone H3-K9 methylation | 6.510037e-4 |
GO:0007096 | regulation of exit from mitosis | 6.510037e-4 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 6.697975e-4 |
GO:0032851 | positive regulation of Rab GTPase activity | 6.900703e-4 |
GO:0006266 | DNA ligation | 6.939700e-4 |
GO:0046823 | negative regulation of nucleocytoplasmic transport | 6.963876e-4 |
GO:0002377 | immunoglobulin production | 7.084035e-4 |
GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter | 7.161482e-4 |
GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway | 7.284897e-4 |
GO:0032536 | regulation of cell projection size | 7.365025e-4 |
GO:0009896 | positive regulation of catabolic process | 7.462870e-4 |
GO:2000173 | negative regulation of branching morphogenesis of a nerve | 7.485161e-4 |
GO:0006420 | arginyl-tRNA aminoacylation | 7.485161e-4 |
GO:0032313 | regulation of Rab GTPase activity | 7.497841e-4 |
GO:0006641 | triglyceride metabolic process | 7.606923e-4 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 7.616568e-4 |
GO:0018924 | mandelate metabolic process | 7.616568e-4 |
GO:0048523 | negative regulation of cellular process | 7.784999e-4 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 7.823400e-4 |
GO:0018026 | peptidyl-lysine monomethylation | 7.823400e-4 |
GO:0008333 | endosome to lysosome transport | 7.871006e-4 |
GO:0010232 | vascular transport | 7.943439e-4 |
GO:2000384 | negative regulation of ectoderm development | 7.943439e-4 |
GO:0014910 | regulation of smooth muscle cell migration | 8.014145e-4 |
GO:0002440 | production of molecular mediator of immune response | 8.085099e-4 |
GO:0031323 | regulation of cellular metabolic process | 8.208503e-4 |
GO:0060174 | limb bud formation | 8.265739e-4 |
GO:0060973 | cell migration involved in heart development | 8.365659e-4 |
GO:0007093 | mitotic cell cycle checkpoint | 8.641631e-4 |
GO:0007625 | grooming behavior | 8.733212e-4 |
GO:0071333 | cellular response to glucose stimulus | 8.752533e-4 |
GO:0010823 | negative regulation of mitochondrion organization | 8.800200e-4 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 8.813324e-4 |
GO:0006657 | CDP-choline pathway | 8.813324e-4 |
GO:0051726 | regulation of cell cycle | 8.865468e-4 |
GO:0050884 | neuromuscular process controlling posture | 8.940450e-4 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 8.973393e-4 |
GO:2000009 | negative regulation of protein localization at cell surface | 9.004814e-4 |
GO:0006683 | galactosylceramide catabolic process | 9.004814e-4 |
GO:0045769 | negative regulation of asymmetric cell division | 9.004814e-4 |
GO:0008612 | peptidyl-lysine modification to hypusine | 9.013430e-4 |
GO:0050658 | RNA transport | 9.101718e-4 |
GO:0045821 | positive regulation of glycolysis | 9.477842e-4 |
GO:0031401 | positive regulation of protein modification process | 9.563561e-4 |
GO:0060487 | lung epithelial cell differentiation | 9.744118e-4 |
GO:0030282 | bone mineralization | 9.744118e-4 |
GO:2000026 | regulation of multicellular organismal development | 9.765852e-4 |
GO:0070875 | positive regulation of glycogen metabolic process | 9.807558e-4 |
GO:0016998 | cell wall macromolecule catabolic process | 9.858209e-4 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 9.877701e-4 |
GO:0001570 | vasculogenesis | 9.897269e-4 |
GO:2000177 | regulation of neural precursor cell proliferation | 1.001020e-3 |
GO:0045844 | positive regulation of striated muscle tissue development | 1.012660e-3 |
GO:0051782 | negative regulation of cell division | 1.013607e-3 |
GO:0002036 | regulation of L-glutamate transport | 1.015502e-3 |
GO:0043587 | tongue morphogenesis | 1.016164e-3 |
GO:0034622 | cellular macromolecular complex assembly | 1.036101e-3 |
GO:0001933 | negative regulation of protein phosphorylation | 1.069794e-3 |
GO:0002344 | B cell affinity maturation | 1.081106e-3 |
GO:0045647 | negative regulation of erythrocyte differentiation | 1.094897e-3 |
GO:0001501 | skeletal system development | 1.110482e-3 |
GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 1.115998e-3 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 1.124594e-3 |
GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine | 1.124594e-3 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 1.145534e-3 |
GO:0051253 | negative regulation of RNA metabolic process | 1.159925e-3 |
GO:0060693 | regulation of branching involved in salivary gland morphogenesis | 1.160815e-3 |
GO:0010827 | regulation of glucose transport | 1.168863e-3 |
GO:0051313 | attachment of spindle microtubules to chromosome | 1.175257e-3 |
GO:0060255 | regulation of macromolecule metabolic process | 1.199375e-3 |
GO:0007519 | skeletal muscle tissue development | 1.234370e-3 |
GO:0034621 | cellular macromolecular complex subunit organization | 1.269151e-3 |
GO:0043096 | purine base salvage | 1.282285e-3 |
GO:0002439 | chronic inflammatory response to antigenic stimulus | 1.285337e-3 |
GO:0072092 | ureteric bud invasion | 1.345212e-3 |
GO:0070836 | caveola assembly | 1.345228e-3 |
GO:0043060 | meiotic metaphase I plate congression | 1.345228e-3 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 1.353939e-3 |
GO:0060024 | rhythmic synaptic transmission | 1.356288e-3 |
GO:0048732 | gland development | 1.358181e-3 |
GO:0051303 | establishment of chromosome localization | 1.368237e-3 |
GO:0001503 | ossification | 1.394521e-3 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 1.427957e-3 |
GO:2000647 | negative regulation of stem cell proliferation | 1.427957e-3 |
GO:0071247 | cellular response to chromate | 1.427957e-3 |
GO:0010933 | positive regulation of macrophage tolerance induction | 1.427957e-3 |
GO:0070563 | negative regulation of vitamin D receptor signaling pathway | 1.427957e-3 |
GO:0010839 | negative regulation of keratinocyte proliferation | 1.427957e-3 |
GO:0035921 | desmosome disassembly | 1.427957e-3 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.451281e-3 |
GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway | 1.501034e-3 |
GO:0018202 | peptidyl-histidine modification | 1.524022e-3 |
GO:0002679 | respiratory burst involved in defense response | 1.524022e-3 |
GO:0060123 | regulation of growth hormone secretion | 1.535811e-3 |
GO:0071286 | cellular response to magnesium ion | 1.573476e-3 |
GO:2000383 | regulation of ectoderm development | 1.600855e-3 |
GO:0006177 | GMP biosynthetic process | 1.600855e-3 |
GO:0006449 | regulation of translational termination | 1.600855e-3 |
GO:0002541 | activation of plasma proteins involved in acute inflammatory response | 1.601316e-3 |
GO:0060312 | regulation of blood vessel remodeling | 1.624259e-3 |
GO:0014816 | satellite cell differentiation | 1.624259e-3 |
GO:0071695 | anatomical structure maturation | 1.631138e-3 |
GO:0001919 | regulation of receptor recycling | 1.635526e-3 |
GO:2000679 | positive regulation of transcription regulatory region DNA binding | 1.672292e-3 |
GO:0001921 | positive regulation of receptor recycling | 1.672292e-3 |
GO:0090181 | regulation of cholesterol metabolic process | 1.715283e-3 |
GO:0042063 | gliogenesis | 1.730574e-3 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.748731e-3 |
GO:0033484 | nitric oxide homeostasis | 1.753595e-3 |
GO:0008054 | cyclin catabolic process | 1.763327e-3 |
GO:0006351 | transcription, DNA-dependent | 1.771641e-3 |
GO:0048643 | positive regulation of skeletal muscle tissue development | 1.783878e-3 |
GO:0051055 | negative regulation of lipid biosynthetic process | 1.788279e-3 |
GO:0051960 | regulation of nervous system development | 1.791127e-3 |
GO:0060479 | lung cell differentiation | 1.822130e-3 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 1.879467e-3 |
GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 1.901730e-3 |
GO:0006413 | translational initiation | 1.903888e-3 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 1.916225e-3 |
GO:0051094 | positive regulation of developmental process | 1.948467e-3 |
GO:0001765 | membrane raft assembly | 1.977720e-3 |
GO:0034453 | microtubule anchoring | 1.980144e-3 |
GO:0014003 | oligodendrocyte development | 1.988892e-3 |
GO:0032774 | RNA biosynthetic process | 2.020745e-3 |
GO:0002070 | epithelial cell maturation | 2.028047e-3 |
GO:0048699 | generation of neurons | 2.054043e-3 |
GO:0045727 | positive regulation of translation | 2.093046e-3 |
GO:0022008 | neurogenesis | 2.095840e-3 |
GO:0032006 | regulation of TOR signaling cascade | 2.110888e-3 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 2.118764e-3 |
GO:0007095 | mitotic cell cycle G2/M transition DNA damage checkpoint | 2.125203e-3 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 2.147220e-3 |
GO:2000119 | negative regulation of sodium-dependent phosphate transport | 2.147220e-3 |
GO:0051882 | mitochondrial depolarization | 2.147220e-3 |
GO:0031860 | telomeric 3' overhang formation | 2.147220e-3 |
GO:0051657 | maintenance of organelle location | 2.195794e-3 |
GO:0060480 | lung goblet cell differentiation | 2.211234e-3 |
GO:0045964 | positive regulation of dopamine metabolic process | 2.211234e-3 |
GO:0016572 | histone phosphorylation | 2.221568e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 2.232674e-3 |
GO:0045950 | negative regulation of mitotic recombination | 2.249426e-3 |
GO:0048343 | paraxial mesodermal cell fate commitment | 2.249426e-3 |
GO:0051775 | response to redox state | 2.263604e-3 |
GO:0050717 | positive regulation of interleukin-1 alpha secretion | 2.263604e-3 |
GO:0022410 | circadian sleep/wake cycle process | 2.295241e-3 |
GO:0022403 | cell cycle phase | 2.321766e-3 |
GO:0007520 | myoblast fusion | 2.369273e-3 |
GO:0046425 | regulation of JAK-STAT cascade | 2.385041e-3 |
GO:0051340 | regulation of ligase activity | 2.388913e-3 |
GO:0006110 | regulation of glycolysis | 2.415579e-3 |
GO:0060215 | primitive hemopoiesis | 2.450929e-3 |
GO:0007051 | spindle organization | 2.523222e-3 |
GO:0060159 | regulation of dopamine receptor signaling pathway | 2.571608e-3 |
GO:0014013 | regulation of gliogenesis | 2.637716e-3 |
GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 2.637721e-3 |
GO:0035910 | ascending aorta morphogenesis | 2.637721e-3 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 2.637721e-3 |
GO:0071841 | cellular component organization or biogenesis at cellular level | 2.674861e-3 |
GO:0001678 | cellular glucose homeostasis | 2.755683e-3 |
GO:0021953 | central nervous system neuron differentiation | 2.777590e-3 |
GO:0008542 | visual learning | 2.787086e-3 |
GO:0060638 | mesenchymal-epithelial cell signaling | 2.818287e-3 |
GO:2000286 | receptor internalization involved in canonical Wnt receptor signaling pathway | 2.843852e-3 |
GO:0051255 | spindle midzone assembly | 2.843852e-3 |
GO:0051899 | membrane depolarization | 2.887937e-3 |
GO:0007628 | adult walking behavior | 2.909342e-3 |
GO:0061002 | negative regulation of dendritic spine morphogenesis | 2.933915e-3 |
GO:0080125 | multicellular structure septum development | 2.974219e-3 |
GO:0070256 | negative regulation of mucus secretion | 2.974219e-3 |
GO:0060783 | mesenchymal smoothened signaling pathway involved in prostate gland development | 2.974219e-3 |
GO:2000063 | positive regulation of ureter smooth muscle cell differentiation | 2.974219e-3 |
GO:2000357 | negative regulation of kidney smooth muscle cell differentiation | 2.974219e-3 |
GO:2000358 | positive regulation of kidney smooth muscle cell differentiation | 2.974219e-3 |
GO:2000062 | negative regulation of ureter smooth muscle cell differentiation | 2.974219e-3 |
GO:0060782 | regulation of mesenchymal cell proliferation involved in prostate gland development | 2.974219e-3 |
GO:0007502 | digestive tract mesoderm development | 2.974219e-3 |
GO:0021526 | medial motor column neuron differentiation | 2.974219e-3 |
GO:0014858 | positive regulation of skeletal muscle cell proliferation | 2.974219e-3 |
GO:0046534 | positive regulation of photoreceptor cell differentiation | 2.974219e-3 |
GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep | 2.974219e-3 |
GO:0007059 | chromosome segregation | 2.991310e-3 |
GO:0035270 | endocrine system development | 3.044808e-3 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 3.045150e-3 |
GO:0050679 | positive regulation of epithelial cell proliferation | 3.135266e-3 |
GO:0045685 | regulation of glial cell differentiation | 3.165945e-3 |
GO:0060525 | prostate glandular acinus development | 3.208915e-3 |
GO:0060516 | primary prostatic bud elongation | 3.226121e-3 |
GO:0072093 | metanephric renal vesicle formation | 3.226121e-3 |
GO:0032075 | positive regulation of nuclease activity | 3.226121e-3 |
GO:0046717 | acid secretion | 3.253370e-3 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 3.253370e-3 |
GO:0042053 | regulation of dopamine metabolic process | 3.280601e-3 |
GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response | 3.292501e-3 |
GO:0060428 | lung epithelium development | 3.337500e-3 |
GO:0042745 | circadian sleep/wake cycle | 3.372308e-3 |
GO:0001945 | lymph vessel development | 3.372308e-3 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 3.416191e-3 |
GO:0043623 | cellular protein complex assembly | 3.505261e-3 |
GO:0021679 | cerebellar molecular layer development | 3.527697e-3 |
GO:0021750 | vestibular nucleus development | 3.527697e-3 |
GO:0021590 | cerebellum maturation | 3.527697e-3 |
GO:0010936 | negative regulation of macrophage cytokine production | 3.527697e-3 |
GO:0006548 | histidine catabolic process | 3.540231e-3 |
GO:0033345 | asparagine catabolic process via L-aspartate | 3.548325e-3 |
GO:0007060 | male meiosis chromosome segregation | 3.548325e-3 |
GO:0001986 | negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure | 3.548325e-3 |
GO:0042362 | fat-soluble vitamin biosynthetic process | 3.551603e-3 |
GO:2000602 | regulation of interphase of mitotic cell cycle | 3.617193e-3 |
GO:0051896 | regulation of protein kinase B signaling cascade | 3.617193e-3 |
GO:0007442 | hindgut morphogenesis | 3.623559e-3 |
GO:0014068 | positive regulation of phosphatidylinositol 3-kinase cascade | 3.657494e-3 |
GO:0031400 | negative regulation of protein modification process | 3.700866e-3 |
GO:0051054 | positive regulation of DNA metabolic process | 3.732421e-3 |
GO:0060556 | regulation of vitamin D biosynthetic process | 3.737165e-3 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 3.764513e-3 |
GO:0060538 | skeletal muscle organ development | 3.801215e-3 |
GO:0090187 | positive regulation of pancreatic juice secretion | 3.820066e-3 |
GO:0090340 | positive regulation of secretion of lysosomal enzymes | 3.820066e-3 |
GO:0090108 | positive regulation of high-density lipoprotein particle assembly | 3.820066e-3 |
GO:0035087 | siRNA loading onto RISC involved in RNA interference | 3.820066e-3 |
GO:0031123 | RNA 3'-end processing | 3.820270e-3 |
GO:0048814 | regulation of dendrite morphogenesis | 3.840645e-3 |
GO:0045787 | positive regulation of cell cycle | 3.844252e-3 |
GO:0060527 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis | 3.855559e-3 |
GO:0045597 | positive regulation of cell differentiation | 3.868648e-3 |
GO:0050767 | regulation of neurogenesis | 3.908878e-3 |